Expanding sales of proprietary health ingredients and equipment and developing new products

「In the Health Business Division, demand remained firm, but performance was generally sluggish due to delays in procuring materials and the impact of the prolonged hot summer, resulting in revenue below the previous fiscal year. In the general bedding products division, revenue temporarily recovered as customers moved to procure winter products early during the summer, but the subsequent reaction and sluggish autumn/winter season resulted in revenue below the previous fiscal year.」

「In the health business division, demand remained resilient, but overall conditions were sluggish due to delays in procuring materials and the impact of the prolonged hot weather, and sales fell below the previous fiscal year.」

「In the Health Business Division, sales of electrothermal quilts and camel products treated with E-Wool processing grew, lifting revenue above the same period of the previous year.」

「In the Health Business Division, market conditions gradually recovered against a backdrop of firm demand in a society with increasing longevity and health awareness, and revenue exceeded the previous fiscal year. In the general bedding products division, winter products struggled due to the mild winter, but revenue exceeded the previous fiscal year partly because summer products performed well.」

「In the Health Business Division, revenue exceeded the same period of the previous year despite sluggish sales of the company's proprietary bio-hemp products for summer use. In the general bedding products division, summer products performed well, and revenue exceeded the same period of the previous year. The operating loss in the healthcare business also narrowed as a result of improved profitability. As a result, healthcare business revenue was ¥531 million, up 8.4% year on year, and the operating loss was ¥14 million, compared with an operating loss of ¥26 million in the same period of the previous year, representing an improvement in the operating loss year on year.」

「In the Health Business Division, sales of electrothermal potential therapy devices and the company's proprietary bio-hemp products grew, lifting revenue above the same period of the previous year. In the general bedding products division, summer products performed well, and revenue exceeded the same period of the previous year. The operating loss in the healthcare business also narrowed as a result of improved profitability. As a result, healthcare business revenue was ¥242 million, up 15.7% year on year, and the operating loss was ¥2 million, compared with an operating loss of ¥21 million in the same period of the previous year, representing an improvement in operating results year on year.」

「In the Health Business Division, sales of the company's proprietary bio-hemp products grew during the summer, but revenue fell below the previous fiscal year due to the delayed recovery in market conditions in some business formats.」

「In the Health Business Division, sales of proprietary bio-hemp products and health bedding using Toyobo technology handled by the former Tetsu Wada Group grew, but revenue fell below the same period of the previous year due in part to the delayed recovery in market conditions.」

「In the Health Business Division, revenue exceeded the same period of the previous year as sales of proprietary bio-hemp products grew. However, in the general bedding products division, a decline in orders related to wool weighed on performance, causing revenue to fall below the same period of the previous year. Overall, healthcare business revenue declined year on year.」

「In the Health Business Division, inquiries increased at the Osaka Sales Department, including orders from new customers for some products for the Beijing Olympics, but sales through face-to-face channels were weak at the Tokyo Sales Department, resulting in lower revenue. In the general bedding products division, revenue increased as orders related to down products grew.」

「In the Health Business Division, sales through face-to-face channels continued to struggle, but demand remained firm, including orders from new customers, albeit in small quantities, including products for the Beijing Olympics. In the general bedding products division, orders for related products such as alpaca and camel products increased, improving revenue. As a result, healthcare business revenue was ¥939 million, compared with ¥925 million in the same period of the previous year, and the operating loss narrowed to ¥3 million from ¥21 million.」

「In the Health Business Division, the division was affected by the delayed recovery in market conditions resulting from the prolonged impact of COVID-19, but its proprietary bio-hemp products grew during the summer. In the general bedding products division, orders gradually recovered. The loss narrowed from the same period of the previous year.」

「In the Health Business Division, efforts focused on marketing medical-related products such as antibacterial materials, but market penetration remained insufficient, and the division was affected by the delayed recovery in market conditions resulting from the prolonged impact of COVID-19. In the general bedding products division, sales benefited from a rebound from the previous year's performance. Profitability was below the same period of the previous year. As a result, healthcare business revenue was ¥250 million, compared with ¥302 million in the same period of the previous year, and the operating loss was ¥17 million, compared with an operating loss of ¥8 million.」

「In the Health Business Division, efforts focused on selling masks as a COVID-19 countermeasure and marketing medical-related products such as antibacterial materials. However, face-to-face sales were sluggish due to the spread of COVID-19, and sleep-related products forming the sales base struggled, resulting in revenue below the previous fiscal year.」

「In the healthcare business, efforts to expand sales of products serving as COVID-19 countermeasures, such as masks and antibacterial materials, did not make a sufficient contribution to results, while the sleep-related products forming the sales base struggled amid the pandemic.」

「In the healthcare business, the Health Business Division focused on selling masks as a COVID-19 countermeasure and marketing medical-related products such as antibacterial materials. However, face-to-face sales were sluggish due to the spread of COVID-19, and revenue fell below the same period of the previous year.」

「In the healthcare business, the health business division focused on selling medical-related products, including masks as a COVID-19 countermeasure and antimicrobial materials. As a result, net sales exceeded those of the same period of the previous year.」

「Going forward, the Group intends to further secure growth in business scale and improve profitability by putting the newly opened Suntomoon Oasis building at Suntomoon Kakita-gawa on a firm footing and strengthening initiatives in medical-adjacent fields, including antimicrobial materials related to COVID-19, in the healthcare business.」

「As a result, net sales in the healthcare business were ¥1,064 million, up 68.2% year on year, and operating profit was ¥13 million, compared with an operating loss of ¥10 million in the same period of the previous year, marking the first return to operating profitability in 5 fiscal years for the third-quarter cumulative consolidated period.」

「As a result, net sales in the healthcare business were ¥651 million, up 80.2% year on year, and operating profit was ¥1 million, compared with an operating loss of ¥13 million in the same period of the previous year, marking the first return to operating profitability in 5 fiscal years for the second-quarter cumulative consolidated period.」

「In the health business division, net sales exceeded those of the same period of the previous year, primarily due to the significant effect of the business acquisition at the end of the previous fiscal year. In the general bedding division, net sales also exceeded those of the same period of the previous year because the business acquisition at the end of the previous fiscal year increased orders for commercial bedding.」

「In the health business division, net sales exceeded those of the previous fiscal year because health bedding, including far-infrared-related products, grew. In the general bedding division, net sales exceeded those of the previous fiscal year, partly due to the effect of consultative sales. In terms of earnings, profit improved year on year due to the effect of higher revenue and improved profitability. As a result, net sales in the healthcare business were ¥832 million, up 10.9% year on year, and the operating loss was ¥29 million, compared with an operating loss of ¥51 million in the previous fiscal year.」

「In the health business division, net sales exceeded those of the same period of the previous year because far-infrared-related health bedding grew. In the general bedding division, net sales exceeded those of the same period of the previous year, mainly due to the success of consultative sales. In terms of earnings, profitability improved year on year as the Company focused on planning, manufacturing and selling health business-related products with resilient demand. As a result, net sales in the healthcare business were ¥633 million, up 9.9% year on year, and the operating loss was ¥10 million, compared with an operating loss of ¥28 million in the same period of the previous year.」

「In the health business division, net sales exceeded those of the same period of the previous year because far-infrared-related health bedding grew. In the general bedding division, net sales fell below those of the same period of the previous year, mainly because summer bedding struggled. In terms of earnings, profitability improved year on year as the Company focused on planning, manufacturing and selling health business-related products with resilient demand.」

「In the healthcare business, the Company worked to promote sales of health business-related products and improve profitability, while continuing discussions concerning the acquisition of the healthcare business that had already been announced.」

「In the healthcare business, the company worked to expand sales of E-Wool products using its proprietary technology and strengthen sales of healthcare products, including household thermal electric potential therapy devices, by leveraging its capital and business alliance with 伊藤超短波株式会社.」

「In the general bedding division, although consultative sales for quilts produced results in early spring, net sales fell below those of the same period of the previous year as sluggish demand for seasonal products, including weaker summer demand, weighed on results.」

「In the health business division, net sales fell below those of the same period of the previous year, mainly because sales by some OEM customers of the Company’s proprietary Bio Hemp products remained sluggish. In the general bedding division, although consultative sales for quilts produced results in early spring, net sales fell below those of the same period of the previous year as weaker summer demand weighed on results.」

「In the health business division, net sales fell below those of the same period of the previous year, mainly because sales by some OEM customers of products made from the Company’s proprietary Bio Hemp material remained sluggish. In the general bedding division, net sales exceeded those of the same period of the previous year, mainly due to the success of consultative sales for quilts.」

「In the healthcare business, the Company worked to strengthen sales of healthcare products, including E-Wool and home-use thermoelectric potential therapy devices developed using its proprietary technology, and began handling e-commerce operations.」

「In the healthcare business, the Company worked to strengthen sales of healthcare products, including E-Wool and home-use thermoelectric potential therapy devices developed using its proprietary technology, and began handling e-commerce operations.」

「In the healthcare business, the Company focused on expanding sales of products such as Bio Hemp, a summer-use health material developed using the Company’s proprietary technology, viewing the extremely hot weather as a business opportunity.」

「In the health business division, net sales exceeded those of the same period of the previous year because home-use thermoelectric potential therapy devices continued to achieve steady sales growth. In the general bedding division, net sales exceeded those of the same period of the previous year because orders for commercial bedding remained strong.」

「In the healthcare business, personnel were shifted to the business, efforts were made to expand sales of the Company’s proprietary products, including the health materials E-Wool and Bio Hemp, and development of new products was undertaken, including E-Wool with antimicrobial and deodorizing properties and compact thermoelectric potential therapy devices.」